Draxxin KP 250ml RX
Zoetis - Draxxin KP (tulathromycin and ketoprofen Injection) injectable antibiotic for cattle contains two ingredients in one shot for fast recovery of BRD.
Draxxin KP (tulathromycin and ketoprofen Injection) injectable antibiotic for cattle contains two ingredients in one shot for fast recovery of BRD. Formulated with the same active ingredient as Draxxin (tularthromycin), with the addition of a non-steroidal anti-inflammatory (NSAID), ketoprofen. Use for the treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. This combination of active ingredients helps cattle recover faster from BRD-related fever, helping them feel better, sooner.* After one dose, Draxxin KP rapidly reaches therapeutic levels and maintains antibacterial therapeutic level for 14 days.
Species: Beef steers, beef heifers, beef calves (2 months of age and older), beef bulls, dairy bulls, and replacement dairy heifers
FEATURES / BENEFITS
Provides significant BRD fever reduction from 1 hour up to 24 hours post treatment in comparison to Draxxin alone.
Same volume dosing as Draxxin Injectable antibiotic for cattle.
One dose provides 14 days of therapy.
*Draxxin KP animals showed numerically improved attitude and respiratory scores compared with saline-treated and Draxxin animals post-treatment.
Meat withhold, 18 days
A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in animals previously found to be hypersensitive to tulathromycin and ketoprofen.
Not for use in beef calves under 2 months of age, dairy calves or veal calves.
Not for use in female dairy cattle 1 year of age or older, including dry dairy cows; use in these cattle may cause drug residues in milk and/or in the calves born to these cows or heifers.
Not for human use. Keep out of reach of children.
Store at or below 25 °C (77 °F), with excursions up to 40 °C (104 °F). Protect from freezing.
Many NSAIDs possess the potential to induce gastrointestinal ulceration, concomitant use of Draxxin KP with other anti-inflammatory drugs, such as other NSAIDs and corticosteroids, should be avoided or closely monitored. Discontinue use if fecal blood is observed.
Administer a single dose at a rate of 1.1 ml per 100 lbs bodyweight subcutaneously in the neck. Do not inject more than 10 ml per injection site.
Use this product within 56 days of the first puncture and puncture a maximum of 20 times. If more than 20 punctures are anticipated, the use of automatic injection equipment or a repeater syringe is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, immediately discard any product remaining in the vial after use.